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YycGF is a crucial signal transduction system for the regulation of cell-wall
metabolism in low-G+C Gram-positive bacteria, which include many important
human pathogens. The response regulator YycF receives signals from its cognate
histidine kinase YycG through a phosphotransfer reaction and elicits responses
through regulation of gene expression. The N-terminal regulatory domain
of YycF from Bacillus subtilis was overproduced and purified. The protein
was crystallized and X-ray data were collected to 1.95 Å resolution with a
completeness of 97.7% and an overall Rmerge of 7.7%. The crystals belonged to
space group P3121, with unit-cell parameters a = b = 59.50, c = 79.06 Å.
1. Introduction
Prokaryotes and some archaea and eukaryotes utilize a two-
component regulatory system (TCS) to sense external or internal
signals and implement appropriate responses through regulation of
gene expression (West & Stock, 2001; Stock et al., 2000). TCSs play
pivotal roles in adaptation, development and pathogenesis. A para-
digmatic TCS consists of a histidine kinase (HK) as the sensor and
a response regulator (RR) that receives the signal from the HK
through phosphotransfer and triggers downstream responses, usually
through regulation of the expression of target genes. A typical
response regulator consists of a regulatory domain that accepts the
phosphoryl group from the cognate histidine kinase and a DNA-
binding or effector domain (Galperin, 2006; Gao et al., 2007). YycGF
is a two-component regulatory system that is specific to low-G+C
Gram-positive bacteria, which include important human pathogens
such as Staphylococcus, Streptococcus and Enterococcus (Winkler &
Hoch, 2008; Fabret & Hoch, 1998; Dubrac et al., 2008). YycG is a
membrane-bound histidine kinase and the response regulator YycF is
a transcription factor that recognizes sequence-specific motifs on the
bacterial DNA chromosome and regulates the expression of certain
genes (Howell et al., 2003; Dubrac & Msadek, 2004). The YycGF
system has been recognized as a crucial signal transduction
mechanism in the regulation of bacterial cell-wall metabolism and cell
division (Dubrac & Msadek, 2004; Fukuchi et al., 2000; Howell et al.,
2003; Mohedano et al., 2005; Ng et al., 2005; Dubrac et al., 2007;
Fukushima et al., 2008). Genes under the putative control of the
YycGF system encode important enzymes involved in cell-wall
synthesis, such as glucosamidase, muramidase, amidase and endo-
peptidase (Dubrac et al., 2007). The YycGF system is essential to
bacterial viability and has been suggested as a target for the
development of novel antibacterial drugs (Watanabe et al., 2008; Qin
et al., 2006; Furuta et al., 2005; Winkler & Hoch, 2008).
TCSs are prevalent in bacteria as indicated by genome-sequence
analysis (West & Stock, 2001; Stock et al., 2000). They are abundant in
most eubacteria, typically constituting 1% of encoded proteins.
The Escherichia coli genome encodes 62 TCS proteins and over 30
TCSs have been identified in Bacillus subtilis. These TCSs mediate
important processes such as environmental stress responses, osmo-
regulation, chemotaxis, phototaxis, virulence, and cell growth and
differentiation. Specificity is an essential feature in HK–RR recog-
nition in TCS signaling, i.e. each RR receives signals only from its
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cognate HK to elicit responses appropriately and there are very few
examples of crosstalk between different TCSs (Skerker et al., 2008;
Gao et al., 2008; Bourret, 2008; Howell et al., 2006). The molecular
basis of this high level of specificity remains to be defined by direct
structural data. YycF belongs to the OmpR/PhoB subfamily of
response regulators. The regulatory domains of most response
regulators in this subfamily share a common ()5 fold, but structural
deviations occur near the phosphorylation site, which presumably
forms the basis for specific recognition between the cognate pairs of
histidine kinases and response regulators (Schnell et al., 2008; Gao et
al., 2007). Crystal structures of the N-terminal regulatory domain of
the YycF homologue from Streptococcus have been described (Bent
et al., 2004). The crystal structure of the DNA-binding domain of
YycF from B. subtilis has been solved (Okajima et al., 2008).
However, structural analysis has not been reported for the histidine
kinases in this and other YycGF orthologs, preventing a full under-
standing of HK–RR recognition in the YycGF system. Recently, we
crystallized a truncated form of the histidine kinase YycG (Zhao &
Tang, 2009). Here, we report preliminary crystallographic character-
ization of the N-terminal regulatory domain of the response regulator
YycF from B. subtilis. The protein has been crystallized and X-ray
data have been collected to 1.95 Å resolution. This should enable
complete structural analysis of this important two-component signal
transduction system and particularly of the molecular determinants
that define the specificity of histidine kinase and response-regulator
recognition.
2. Materials and methods
2.1. Protein overproduction and purification
The construct yycF120 encoding residues 1–120 of YycF (YycF120)
was PCR-amplified from B. subtilis strain 168 genomic DNA with the
use of the following primers: 50-CCACCATGGATAAAAAGATC-
CTTGTAG-30, which contains an NcoI site followed by the 50-coding
sequence of yycF120, and 50-CTCCTCGAGTTACTGGCGGCGC-
AGGTTC-30, which harbours the 30-coding sequence of yycF120, a
stop codon and an XhoI site. After digestion of PCR-amplified DNA
with NcoI and XhoI, it was ligated with pET28a (Novagen) plasmid
cut with NcoI and XhoI enzymes. The protein YycF120 was over-
produced in BL21 (DE3) E. coli cells grown at 303 K in LB medium.
Frozen cell pellets were resuspended in 20 mM Tris–HCl pH 7.5,
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Figure 1
Size-exclusion chromatogram using a Sephacryl 26/60 S-300 column (GE
Healthcare) showing a major peak at 215.5 ml corresponding to an approximate
molecular mass of 17 kDa, consistent with a YycF120 monomer. The column was
calibrated using the molecular-weight markers in the MWGF1000 Kit (Sigma)
following the procedure suggested by the manufacturer.
Figure 2
Crystals of the YycF N-terminal regulatory domain. The largest crystal is
approximately 0.4  0.2  0.2 mm. The smallest division of the ruler corresponds
to 0.022 mm.
Figure 3
A diffraction pattern of a crystal of the YycF N-terminal regulatory domain. A
close-up of an outer region is shown. Rings are shown for 1.7, 2.3, 3.5 and 7.0 Å
resolution.
50 mM NaCl, 1 mM EDTA and 1 mM DTT (buffer A), sonicated and
centrifuged to remove cell debris. The supernatant was loaded onto a
HiTrap Q FF (GE Healthcare) column, washed and eluted with
buffer A plus 500 mM NaCl (buffer B). The fractions containing
YycF120 were pooled and dialyzed against 20 mM sodium phosphate
pH 6.2, 50 mM NaCl, 1 mM EDTA and 1 mM DTT (buffer C). This
preparation was loaded onto a MonoQ column (1 ml; GE Health-
care) and eluted with buffer C plus 500 mM NaCl (buffer D). The
major fractions containing YycF120 were then loaded onto a size-
exclusion chromatography column (Sephacryl S-300, GE Healthcare)
and eluted with 20 mM Tris–HCl pH 8.5, 150 mM NaCl, 1 mM EDTA
and 1 mM DTT. The fractions containing YycF120 were combined
and concentrated with Amicon Ultra-4 10 000 MWCO (Millipore).
The final preparation of YycF120 was concentrated to 15 mg ml1 for
subsequent crystallization trials. Electrospray ionization mass spec-
trometry showed a molecular mass of 13 765.5 Da, which is in
agreement with the calculated mass. Size-exclusion chromatography
showed that the protein existed as a monomer in solution (Fig. 1).
2.2. Crystallization
Initial crystallization screening was performed using the Wizard I,
II and III random sparse-matrix crystallization screen kits commer-
cially available from Emerald BioStructures. The conditions were
optimized and the optimal crystals were grown at 293 K by the
hanging-drop vapour-diffusion method. 1 ml protein solution at
15 mg ml1 was mixed with an equal volume of reservoir solution
containing 0.1 M Tris–HCl pH 8.5, 12% glycerol and 1.5 M ammo-
nium sulfate and was equilibrated against 500 ml reservoir solution.
Crystals grew to maximal dimensions of approximately 0.4  0.2 
0.2 mm within four weeks (Fig. 2).
2.3. Data collection and processing
Crystals were flash-cooled in liquid nitrogen using 25% glycerol as
a cryoprotectant. X-ray data were collected at a cryogenic tempera-
ture of 100 K on beamline X29 at the National Synchrotron Light
Source (NSLS, New York) using an ADSC Quantum-315r CCD
detector. A total of 200 frames were collected with an oscillation
range of 1 and an exposure time of 0.5 s per frame (Fig. 3). The
diffraction data were processed with HKL-2000 (Otwinowski &
Minor, 1997). Data-collection and processing statistics are summar-
ized in Table 1.
3. Results and discussion
The N-terminal regulatory domain of YycF encompassing residues
1–120 was purified using three chromatographic columns. We
observed the presence of both unphosphorylated and phosphorylated
versions of YycF120 on overproduction in E. coli, although the
unphosphorylated protein dominated (Fig. 4). The use of a MonoQ
column was essential for separation of the two versions and successful
crystallization of the purified unphosphorylated YycF120. This also
enabled purification of the phosphorylated YycF120, which may
allow comparative structural studies to shed light on plausible con-
formational changes induced by phosphorylation as a mechanism for
YycF activation.
Crystals of YycF120 belonged to space group P3121, with unit-cell
parameters a = b = 59.50, c = 79.06 Å. The data set contained a total of
11 994 unique reflections in the resolution range 50.0–1.95 Å, with a
completeness of 97.7% and an Rmerge of 7.7%. The data were
analyzed with the program PHENIX (Adams et al., 2002) and no
twinning was detected. The crystal contained one molecule in the
crystallographic asymmetric unit, with 58% solvent content and a
VM value of 2.9 Å
3 Da1 (Matthews, 1968). The structure has been
determined using the molecular-replacement method and deposited
in the RCSB Protein Data Bank with accession code 3f6p. Details of
the structure will be reported elsewhere.
The X-ray data for this study were measured on beamline X29 of
the National Synchrotron Light Source. Financial support came
principally from the Offices of Biological and Environmental
Research and of Basic Energy Sciences of the US Department of
Energy and from the National Center for Research Resources of the
National Institutes of Health. We thank Dr Nadezhda Gelava at the
University of Kansas Analytical Proteomics Laboratory for assis-
tance in mass spectrometry. This work was supported by the NIH/
NCRR COBRE program P20RR17708.
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i IiðhklÞ, where Ii(hkl) is the observed
intensity of reflection hkl and hI(hkl)i is the averaged intensity of symmetry-equivalent
measurements.
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